TrypLE™ Select is a recombinant enzyme free of animal-derived components, allowing the dissociation of a wide range of mammalian cells, including: CHO, HEK 293, A529, primary keratinocytes of human origin and stem cells.
TrypLE™ Select is a recombinant enzyme free of animal-derived components, allowing the dissociation of a wide range of mammalian cells, including: CHO, HEK 293, A529, primary keratinocytes of human origin and embryonic stem cells. We offer a variety of TrypLE™ formulations for a range of cell culture applications.
Compared to trypsin and other dissociation reagents, the Gibco™ TrypLE™ Select solution is:
Non-aggressive for cells: preserves the health of cells to achieve reproducible results
Stable at room temperature: convenient to use
Easy to use: substitutes directly in existing protocols, without any inactivation required
Animal component free (AOF): pure, homogeneous and effective
TrypLE™ Select, like trypsin, cleaves the peptide bonds on the C-terminal sides of lysine and lysine. The exceptional purity of TrypLE™ Select nevertheless increases specificity by the action of a single enzyme. This reduces damage caused by the cleavage of several enzymes in trypsin and other extracts.
TrypLE™ Select is stable at room temperature and ready to use. TrypLE™ Select cell dissociation reagents remain stable for 24 months at room temperature or 2 at 8°C, making storage and handling easier and more convenient.
TrypLE™ Select can be substituted for trypsin in existing protocols. In addition, dilution alone disables TrypLE™ Select, thus avoiding the need for trypsin inhibitors, such as SVF.
Without animal origin component (AOF)
Unlike porcine trypsin and other enzymes, TrypLE™ Select is free of animal-derived components and is formulated on dedicated equipment without animal-derived components.
Planned use of the product
For research or further manufacturing purposes. Do not use for diagnostic procedures. Customers using Gibco™ TrypLE™ Select in a manufacturing process, who must submit to FDA, can request a letter of authorization to refer to our DMF Master Drug File.
Quality system and BPFa compliant manufacturing
Gibco™ TrypLE™ Select is manufactured on a BPFa site located in Grand Island, New York. The site is certified by FDA as a manufacturer of medical devices and is certified to ISO 13485.
The concentrated forms of TrypLE™ can be diluted aseptically to 1x using a balanced saline solution containing 1 mM of EDTA.